EICHORCondition: Systemic Lupus Erythematosus, SLE · Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a phase IIb, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of orelabrutinib in adult subjects with SLE who are receiving standard of care (SOC) therapy.
This description comes directly from the study's public registry record.
Zhanguo Li, PhD · 010-88324172 · Zgli@yahoo.cn
Always discuss trial participation with your own doctor first.
| The first affiliated hospital of bengbu medical college | Bengbu, Anhui, China | Recruiting |
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of XiaMen University | Xiamen, Fujian, China | Recruiting |
| The First Affiliated Hospital,Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| The first affiliated hospital of shantou university medical college | Shantou, Guangdong, China | Recruiting |
| The Seventh Affiliated Hospital, Sun Yat-sen University | Shenzhen, Guangdong, China | Recruiting |
| Affiliated Hospital of Guilin Medical University | Guilin, Guangxi, China | Recruiting |
| Affiliated Hospital of HeBei University | Baoding, Hebei, China | Recruiting |
| Hebei People's Hospital | Shijiazhuang, Hebei, China | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05688696